Appendicitis Blood-based Test - AspenBio Pharma Reports Preliminary Results Of AppyScore(TM) Clinical Study

AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, reported initial preliminary data from its Food and Drug Administration (”FDA”) clinical trial for AppyScore(TM), the world’s first blood-based test as an aid in the diagnosis of human appendicitis and an update on planned steps for pursuing FDA market authorization in the U.S.

More: continued here

Filed under: GastroIntestinal / Gastroentorology on January 25th, 2009